...This represents one of our most important programs at Ionis, particularly as we are getting ready to readout our Phase 3 programs. So we're very excited to be able to present an educational session today with our world-renowned experts to review this topic. My name is Sam Tsimikas. I'm the Cardiovascular Franchise Leader at Ionis. And my background is as a cardiologist and very interested in the pathophysiology of cardiovascular disease, particularly as it relates to various lipid disorders. Today, we have an esteem panel of experts that will help me and you lead the discussion on hypertriglyceridemia. And we have Dr. Seth Baum. We have Dr. Savitha Subramanian, and Dr. Alan Brown, and I'm going to allow them to introduce themselves in a little bit. But first, let me just go over the agenda for today. We have four main objectives. One is to learn about the pathophysiology of hypertriglyceridemia, especially severe hypertriglyceridemia and its prevalence. Then, we want to go over what these...
